EUVIMEDEUVIMED entdecken
Crossref

ALS iPSC-derived microglia and motor neurons respond to astrocyte-targeted IL-10 and CCL2 modulation

Reilly L Allison, Allison D Ebert iD

Human Molecular Genetics · 2024

DOI: 10.1093/hmg/ddad209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Reilly L Allison und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226, United States. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Induced Pluripotent Stem Cells, Neurodegenerative Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Medical College of Wisconsin Center for Immunology, Neuroscience Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the loss of upper and lower motor neurons (MNs). The loss of MNs in ALS leads to muscle weakness and wasting, respiratory failure, and death often within two years of diagnosis. Glial cells in ALS show aberrant expression of pro-inflammatory and neurotoxic proteins associated with activation and have been proposed as ideal therapeutic targets. In this study, we examined astrocyte-targeted treatments to reduce glial activation and neuron pathology using cells differentiated from ALS patient-derived iPSC carrying SOD1 and C9ORF72 mutations. Specifically, we tested the ability of increasing interleukin 10 (IL-10) and reducing C-C motif chemokine ligand 2 (CCL2/MCP-1) signaling targeted to astrocytes to reduce activation phenotypes in both astrocytes and microglia. Overall, we found IL10/CCL2NAb treated astrocytes to support anti-inflammatory phenotypes and reduce neurotoxicity, through different mechanisms in SOD1 and C9ORF72 cultures. We also found altered responses of microglia and motor neurons to astrocytic influences when cells were cultured together rather than in isolation. Together these data support IL-10 and CCL2 as non-mutation-specific therapeutic targets for ALS and highlight the role of glial-mediated pathology in this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisInduced Pluripotent Stem CellsNeurodegenerative DiseasesHumansInterleukin-10AstrocytesC9orf72 ProteinMicrogliaSuperoxide Dismutase-1Motor NeuronsChemokine CCL2

Stichwörter der Autor:innen

induced pluripotent stem cellsneurodegenerationneuroinflammationphagocytosis

Substanzen

Interleukin-10C9orf72 ProteinSuperoxide Dismutase-1CCL2 protein, humanChemokine CCL2

Autor:innen und Institutionen

  • Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226, United States.

ORCID-Profile: Allison D Ebert

Förderung

  • Medical College of Wisconsin Center for Immunology
  • Neuroscience Research Center

Zitieren

APA

Allison, R. L., & Ebert, A. D. (2024). ALS iPSC-derived microglia and motor neurons respond to astrocyte-targeted IL-10 and CCL2 modulation. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddad209

Vancouver

Allison RL, Ebert AD. ALS iPSC-derived microglia and motor neurons respond to astrocyte-targeted IL-10 and CCL2 modulation. Human Molecular Genetics. 2024. doi:10.1093/hmg/ddad209

BibTeX
@article{Allison2024,
  author = {Allison, Reilly L and Ebert, Allison D},
  title = {ALS iPSC-derived microglia and motor neurons respond to astrocyte-targeted IL-10 and CCL2 modulation},
  journal = {Human Molecular Genetics},
  year = {2024},
  doi = {10.1093/hmg/ddad209}
}
Kostenlos starten →